The accurate analysis allows describing modern treatment methods in detail. Find descriptions, advantages, results, and statistics for the latest treatment approaches.
Men with prostate cancer have many ways to get treatment, such as surgery, radiation therapy, chemotherapy, hormonal therapy, and immunotherapy. When androgens, which are male sex hormones, move through the bloodstream, they can make prostate cancer grow. One type of prostate cancer treatment lowers the level of androgens in the body or stops them from doing their job. Even with these treatments, some prostate cancers keep getting worse. Castration-resistant prostate cancer is the name for this type of cancer (CRPC).
Most TACEs require about 90 minutes. About 70% of the patients will have their liver problems get better. TACE therapy can be repeated in 1-2 months after the first procedure. TACE can halt tumors from expanding or make them smaller in about two-thirds of cases.
TACP combined with brachytherapy had a 2-year survival rate of 63.5%. 84.2% of breast cancer patients with liver metastases got better with TACP. TACP shows a 70.3% disease control rate of inoperable malignant pleural mesothelioma. Transarterial chemoperfusion shows 70% positive results (7,5% complete response, 22,5% partial response, 40% stable) in patients with recurred and advanced pancreatic carcinoma.
Due to the studies, proton therapy for liver cancer helps to free from cancer 46% of people after 3 years. Up to 60% less radiation is sent to the tissues around the tumor because of this treatment. Proton therapy patients had a 31-month survival rate, compared to 14 months for radiation therapy patients.
95 to 100% of patients with low-risk prostate cancer treated with HIFU were alive after ten years. The HIFU procedure for prostate cancer helps avoid radical prostate cancer treatment in 91% of patients. The high-frequency ultrasound treatment’s metastasis-free survival rate was 95% for 15 years.
With HIFU alone, the 1-year survival rate for liver cancer is about 80%. More than half of the tumor cells died after just one HIFU for liver cancer. Ultrasound heats cancer cells to more than 60°C in one second, destroying tumor proteins. The complication rate is 8.1% for patients with hepatocellular carcinoma after HIFU treatment.